APPLICATION
ANDA216096
TYPE
ANDA
ORIGINAL APPROVAL
2022-05-24
LATEST ACTION
2025-06-05
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED RELEASE
MARKETING STATUS
Over-the-counter
Products
OMEPRAZOLE MAGNESIUMOver-the-counter
OMEPRAZOLE MAGNESIUM EQ 20MG BASE · CAPSULE, DELAYED RELEASE · ORAL
Approval history
2025-06-05Manufacturing (CMC) · Supplement 5 · unknownAP
2023-07-20Labeling · Supplement 2 · standardAP
2022-05-24UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.